Loading viewer...
investor_presentation
Format: PDF investor_presentation
COMPANY ADMINISTRATION from Dimerix (ASX)
Dimerix Phase 3 Trial Last Patient Receives First Dose
presentation
investor_presentation
36 Pages
Lear Corporation
Iovance Biotherapeutics Investor Presentation — June 2019
investor_presentationinvestor_presentation
37 Pages
Iovance Biotherapeutics, Inc